Skeletal muscle magnesium content in identical twins, discordant for type 2 diabetes

Diabetes and Metabolism

Volumn 28, Issue 3, 2002, Pages 201-207

  Djurhuus, M S ^a   Vaag, A ^a   Altura, B M ^a   Altura, B T ^a   Klitgaard, N A H ^a  

^a NONE   (Denmark)

Author keywords

Genetics; Insulin resistance syndrome; Metabolic syndrome; Syndrome X

Indexed keywords

MAGNESIUM; GLUCOSE;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE PREDISPOSITION; FEMALE; GLUCOSE METABOLISM; GLUCOSE TRANSPORT; HUMAN; INSULIN BLOOD LEVEL; INSULIN SENSITIVITY; MAGNESIUM BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MONOZYGOTIC TWINS; NON INSULIN DEPENDENT DIABETES MELLITUS; ORAL GLUCOSE TOLERANCE TEST; SKELETAL MUSCLE; TISSUE LEVEL; TWIN DISCORDANCE; ADOLESCENT; BLOOD; COMPARATIVE STUDY; GLUCOSE BLOOD LEVEL; GLUCOSE CLAMP TECHNIQUE; GLUCOSE TOLERANCE TEST; METABOLISM; MIDDLE AGED; REFERENCE VALUE; TWINS;

ADOLESCENT; ADULT; AGED; BLOOD GLUCOSE; COMPARATIVE STUDY; DIABETES MELLITUS, NON-INSULIN-DEPENDENT; FEMALE; GLUCOSE; GLUCOSE CLAMP TECHNIQUE; GLUCOSE TOLERANCE TEST; HUMAN; MAGNESIUM; MALE; MIDDLE AGE; MUSCLE, SKELETAL; REFERENCE VALUES; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.; TWINS, MONOZYGOTIC; DIABETES MELLITUS, TYPE 2; HUMANS; MIDDLE AGED;

EID: 0035986339     PISSN: 12623636     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Magnesium deficiency in IDDM related to level of glycosylated hemoglobin
2. Oral administration of magnesium hydroxide to subjects with insulin-dependent diabetes mellitus: Effects on magnesium and potassium levels and on insulin requirements
3. Evidence for a disturbed magnesium metabolism in diabetes mellitus
4. Magnesium, potassium and zinc deficiency in subjects with type II diabetes mellitus
5. Effect of moderate improvement in metabolic control on magnesium and lipid concentrations in patients with type 1 diabetes
6. Hyperglycaemia enhances renal magnesium excretion in Type 1 diabetic patients
7. Insulin increases renal magnesium excretion: A possible cause of magnesium depletion in hyperinsulinaemic states
8. Is low magnesium concentration a risk factor for coronary heart disease? The atherosclerosis risk in communities (ARIC) study
9. Magnesium deficiency in patients with ischemic heart disease with and without acute myocardial infarction uncovered by an intravenous loading test
10. Influence of magnesium substitution therapy on blood lipid composition in patients with ischemic heart disease. A double-blind, placebo controlled study
11. Effect of dietary magnesium supplementation in the prevention of coronary heart disease and sudden cardiac death
12. Associations of serum and dietary magnesium with cardiovascular disease, hypertension, diabetes, insulin, and carotid arterial wall thickness: The ARIC study. Atherosclerosis risk in communities study
13. Ionized and total magnesium levels in cyclosporin-treated renal transplant recipients: Relationship with cholesterol and cyclosporin levels
14. Monotherapy with magnesium increases abnormally low high density lipoprotein cholesterol: A clinical assay
15. Magnesium pyridoxal 5-phosphate glutamate reduces hyperlipidaemia in patients with chronic renal insufficiency
16. Ionized magnesium measurements in serum, plasma and whole blood in health and disease
17. Oral magnesium supplementation in patients with essential hypertension
18. Improved insulin response and action by chronic magnesium administration in aged NIDDM subjects
19. Changes in glucose turnover parameters and improvement of glucose oxidation after 4-week magnesium administration in elderly noninsulin-dependent (type II) diabetic patients
20. Effect of oral magnesium supplementation on selected cardiovascular risk factors in non-insulin-dependent diabetics
21. Hypomagnesemia in type II diabetes: Effect of a 3-month replacement therapy
22. Magnesium supplementation to patients with type II diabetes
23. Oral magnesium supplementation in insulin-requiring Type 2 diabetic patients
24. Effect of magnesium treatment on glycemic control and metabolic parameters in NIDDM patients
25. The effect of magnesium supplementation in increasing doses on the control of type 2 diabetes
26. Magnesium supplementation reduces insulin-stimulated glucose uptake and serum lipid concentrations in type 1 diabetes
27. Insulin secretion, insulin action, and hepatic glucose production in identical twins discordant for non-insulin-dependent diabetes mellitus
28. Methodological aspects of measuring human skeletal muscle electrolyte content and ouabain binding capacity
29. The muscle in diabetes mellitus. A histologic (light and electron microscope) and biochemical study by means of needle biopsy
30. New data on the mechanisms of hypermagnesuria in type 1 diabetes mellitus
31. Changes of calcemia and magnesemia during oral glucose tolerance test (OGTT) in relation to glucose tolerance